Cargando…

Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16

Personalized treatment targeting the epidermal growth factor receptor (EGFR) may be a promising new treatment of non-small cell lung cancer (NSCLC). Gefitinib, a tyrosine kinase inhibitor, is the first drug for NSCLC, which unfortunately easily leads to drug resistance. Our study aimed to explore th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ning, Zhang, Tingting
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844745/ https://www.ncbi.nlm.nih.gov/pubmed/29295721 http://dx.doi.org/10.3727/096504017X15144755633680

Ejemplares similares

miR-135a Confers Resistance to Gefitinib in Non-Small Cell Lung Cancer Cells by Upregulation of RAC1
por: Zhang, Tingting, et al.
Publicado: (2018)

MicroRNA-30e reduces cell growth and enhances drug sensitivity to gefitinib in lung carcinoma
por: Ning, Zhi-Qiang, et al.
Publicado: (2016)

Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
por: Sin, Thomas K., et al.
Publicado: (2016)

Serum microRNA-135a as a diagnostic biomarker in non-small cell lung cancer
por: Zou, Yuanwu, et al.
Publicado: (2019)

MicroRNA-1 inhibits tumorigenicity of esophageal squamous cell carcinoma and enhances sensitivity to gefitinib
por: Yu, Qianqian, et al.
Publicado: (2018)

Functional role of microRNA-135a in colitis
por: Lou, Chunyan, et al.
Publicado: (2018)

Axl-altered microRNAs regulate tumorigenicity and gefitinib resistance in lung cancer
por: Wang, Y, et al.
Publicado: (2014)

MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral Factors
por: Sodroski, Catherine, et al.
Publicado: (2018)

Overcoming the Intrinsic Gefitinib-resistance via Downregulation of AXL in Non-small Cell Lung Cancer
por: Jeong, Inae, et al.
Publicado: (2019)

MicroRNA-135a promotes proliferation, migration, invasion and induces chemoresistance of endometrial cancer cells
por: Wang, Jiping, et al.
Publicado: (2019)

TAZ sensitizes EGFR wild-type non-small-cell lung cancer to gefitinib by promoting amphiregulin transcription
por: Yuan, Weiwei, et al.
Publicado: (2019)

MicroRNA-215 suppresses the proliferation, migration and invasion of non-small cell lung carcinoma cells through the downregulation of matrix metalloproteinase-16 expression
por: Yao, Yuanshan, et al.
Publicado: (2018)

Identification of microRNAs involved in gefitinib resistance of non-small-cell lung cancer through the insulin-like growth factor receptor 1 signaling pathway
por: Ma, Wei, et al.
Publicado: (2017)

Downregulation Of microRNA-133b And Its Clinical Value In Non-Small Cell Lung Cancer
por: Chen, Guan-yu, et al.
Publicado: (2019)

Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193
por: Pan, Yue, et al.
Publicado: (2019)

MicroRNA-135a Regulates Apoptosis Induced by Hydrogen Peroxide in Rat Cardiomyoblast Cells
por: Liu, Ning, et al.
Publicado: (2017)

Gefitinib in Non Small Cell Lung Cancer
por: Costanzo, Raffaele, et al.
Publicado: (2011)

The Tumor-Suppressive MicroRNA-135b Targets c-Myc in Osteoscarcoma
por: Liu, Zheng, et al.
Publicado: (2014)

Clinical value of microRNA-135a and MMP-13 in colon cancer
por: Zhou, Xinjun, et al.
Publicado: (2021)

Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells
por: Li, Jiajin, et al.
Publicado: (2016)

Interferon-α reduces the gefitinib sensitivity of human non-small cell lung cancer
por: Pan, Chi, et al.
Publicado: (2016)

Increased glutamine anabolism sensitizes non-small cell lung cancer to gefitinib treatment
por: Wang, Liang, et al.
Publicado: (2018)

Downregulation of microRNA-100 protects apoptosis and promotes neuronal growth in retinal ganglion cells
por: Kong, Ning, et al.
Publicado: (2014)

MicroRNA-138 Increases Chemo-Sensitivity of Glioblastoma through Downregulation of Survivin
por: Yoo, Ji-Young, et al.
Publicado: (2021)

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
por: Garofalo, Michela, et al.
Publicado: (2011)

MicroRNA-122 negatively associates with peroxiredoxin-II expression in human gefitinib-resistant lung cancer stem cells
por: Chandimali, Nisansala, et al.
Publicado: (2018)

Serum-based microRNA biomarkers for major depression: MiR-16, miR-135a, and miR-1202
por: Gheysarzadeh, Ali, et al.
Publicado: (2018)

MicroRNA-218 Is Deleted and Downregulated in Lung Squamous Cell Carcinoma
por: Davidson, Morgan R., et al.
Publicado: (2010)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2007)

MicroRNA-4491 enhances cell proliferation and inhibits cell apoptosis in non-small cell lung cancer via targeting TRIM7
por: Han, Fei, et al.
Publicado: (2021)

MicroRNA-7 enhances cytotoxicity induced by gefitinib in non-small cell lung cancer via inhibiting the EGFR and IGF1R signalling pathways
por: Zhao, Jun-gang, et al.
Publicado: (2015)

MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells
por: Du, Zhonghai, et al.
Publicado: (2019)

Retraction: The Tumor-Suppressive MicroRNA-135b Targets c-Myc in Osteoscarcoma
Publicado: (2023)

MicroRNA-135b Promotes Cancer Progression by Acting as a Downstream Effector of Oncogenic Pathways in Colon Cancer
por: Valeri, Nicola, et al.
Publicado: (2014)

MicroRNA-7 sensitizes non-small cell lung cancer cells to paclitaxel
por: LIU, RONGHUA, et al.
Publicado: (2014)

HMGB1-mediated autophagy promotes gefitinib resistance in human non-small cell lung cancer: HMGB1-mediated autophagy promotes gefitinib resistance
por: Lei, Tianyao, et al.
Publicado: (2022)

MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer
por: Fanini, Francesca, et al.
Publicado: (2021)

MicroRNA-216a-3p promotes sorafenib sensitivity in hepatocellular carcinoma by downregulating MAPK14 expression
por: Wan, Zhong, et al.
Publicado: (2020)

HOTAIR promotes gefitinib resistance through modification of EZH2 and silencing p16 and p21 in non-small cell lung cancer
por: Li, Weiting, et al.
Publicado: (2021)

MicroRNA-503 and the Extended MicroRNA-16 Family in Angiogenesis
por: Caporali, Andrea, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3a2dmrrsmg1lm3f5l869n6g690